Cresco Labs faced a class action lawsuit in Illinois after marketing products without the required FDA approval.
2 reports, 1 independent
Updated Jan 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cresco Labs faced a class action lawsuit in Illinois after marketing products without the required FDA approval.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- An Illinois company supplied a lethal cocktail to Georgia, following the FDA's approval of the original anesthetic drug.Sub-event
Cresco Labs marketed products without FDA approval, leading to a class action in Illinois.1 source
Keep exploring
The entities involved
- FDA
-
Cresco Labs
American cannabis company
Nothing else this week.
-
Illinois
state of the United States of America
Related events
- DEA guidance restricts state-licensed supply chains in Pennsylvania, relating to FDA-approved products.
- The FDA is a U.S. government agency, a basic descriptive fact about the regulator.
- The Food and Drug Administration (FDA) oversees product safety and recalls.
- Bracco, based in Princeton, N.J., requires FDA approval for its products.
- Eton secures exclusive U.S. commercialization rights, with FDA acceptance driving the Anaphylm PDUFA date.